Drug Trial Radar · NCT04002297
A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation
Last checked: Nov 20, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
510
Actual
Start
Aug 20, 2019
Primary completion
Apr 27, 2026
Study completion Sep 30, 2031
Sponsor
- Lead sponsor
- BeOne MedicinesBeOne Medicines (BeiGene) (ONC)
- Sponsor type
- Industry
- First posted
- Jun 28, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized study to compare the efficacy and safety of zanubrutinib plus rituximab versus bendamustine plus rituximab in previously untreated participants with mantle cell lymphoma (MCL) who are not eligible for stem cell transplantation.
Conditions
- Mantle Cell Lymphoma; Non-Hodgkin Lymphoma
Interventions
zanubrutinibDrug
Administered as two 80 mg capsules by mouth twice a day
bendamustineDrug
Administered intravenously at a dose of 90 mg/m2/day on Days 1 and 2 of Cycles 1 to 6
rituximabDrug
Administered intravenously at a dose of 375 mg/m2 on Day 1 of Cycles 1 to 6
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS) determined by independent central reviewTime frame: Up to approximately 7 years
Locations
176 sites in 22 countries. Site status is shown where the registry gives one.
Chao Family Comprehensive Cancer Center
Orange, California
Rush University Medical Center
Chicago, Illinois
Beth Israel Deaconess Medical Center (Bidmc)
Boston, Massachusetts
University of Michigan Health System
Ann Arbor, Michigan
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada
Icahn School of Medicine At Mount Sinai
New York, New York
Clinical Research Alliance, Inc
Westbury, New York
Providence Portland Medical Center
Portland, Oregon
West Penn Hospital
Pittsburgh, Pennsylvania
The University of Texas Md Anderson Cancer Center
Houston, Texas
Joe Arrington Cancer Research and Treatment Center
Lubbock, Texas
Seattle Cancer Care Alliance
Seattle, Washington
Canberra Hospital
Garran, Australian Capital Territory, Australia
Concord Repatriation General Hospital
Concord, New South Wales, Australia
The Tweed Valley Hospital
Cudgen, New South Wales, Australia
Saint Vincents Hospital Sydney
Darlinghurst, New South Wales, Australia
Gosford Hospital
Gosford, New South Wales, Australia
Calvary Mater Newcastle
Waratah, New South Wales, Australia
Sunshine Coast Hospital and Health Service
Birtinya, Queensland, Australia
Icon Cancer Foundation
South Brisbane, Queensland, Australia
Flinders Medical Centre
Bedford PK, South Australia, Australia
Royal Hobart Hospital
Hobart, Tasmania, Australia
Monash Health
Clayton, Victoria, Australia
St Vincents Hospital Melbourne
Fitzroy, Victoria, Australia
Peninsula Private Hospital
Frankston, Victoria, Australia
Barwon Health the Geelong Hospital
Geelong, Victoria, Australia
Royal Perth Hospital
Perth, Western Australia, Australia
Ordensklinikum Linz Gmbh Elisabethinen
Linz, Austria
Universitatsklinik Fur Innere Medizin Iii Universitatsklinikum Der Pmu Landeskrankenhaus Salzburg
Salzburg, Austria
Medical University Vienna Oncology
Vienna, Austria
Az Sint Jan Brugge
Bruges, Belgium
Universitair Ziekenhuis Brussel
Brussels, Belgium
Uz Antwerpen
Edegem, Belgium
Az Groeninge Campus Loofstraat
Kortrijk, Belgium
Centre Hospitalier Universitaire (Chu) de Liege Site Du Sart Tilman
Liège, Belgium
Centre Hospitalier Universitaire Universite Catholique de Louvain Site Godinne
Yvoir, Belgium
The Ottawa Hospital
Ottawa, Ontario, Canada
Ciusss de Lestrie Chus
Sherbrooke, Quebec, Canada
Peking University Peoples Hospital
Beijing, Beijing Municipality, China
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Showing 40 of 176 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.